Medicare Enrolled

Dr. Manish Damani, MD

Optician · Charlotte, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1718 E 4TH ST, Charlotte, NC 28204
7043755755
In practice since 2006 (20 years)
NPI: 1649210485 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Damani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Damani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Damani

Dr. Manish Damani is an optician specialist in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Damani performed 1,307 Medicare services across 962 unique beneficiaries.

Between the years covered by Open Payments, Dr. Damani received a total of $4,196 from 36 pharmaceutical and/or device companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Damani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 42% volume in NC $4,196 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,307
Medicare services
Top 42% in NC for optician
962
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~65 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
219 $7 $45
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
205 $3 $17
Leuprolide acetate (for depot suspension), 7.5 mg 126 $136 $786
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
124 $62 $110
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
104 $8 $10
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
81 $173 $582
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
75 $83 $158
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
48 $21 $80
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
43 $23 $87
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
43 $79 $185
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
38 $19 $264
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
35 $115 $263
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
31 $4 $17
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
25 $168 $614
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
25 $102 $294
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
17 $197 $798
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $116 $231
Complicated insertion of bladder tube 15 $115 $461
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
13 $114 $1,454
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
12 $81 $550
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
12 $39 $91
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
29.0% medium
70.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,196
Total received (2018-2024)
Avg $599/year across 7 years
Top 26% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,096 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,082
2023
$827
2022
$705
2021
$405
2020
$310
2019
$409
2018
$458

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$251
BIOPROTECT MEDICAL, INC.
$163
UROGEN PHARMA, INC.
$137
Myriad Genetic Laboratories, Inc.
$121
Olympus America Inc.
$102
Astellas Pharma US Inc
$81
ABBVIE INC.
$65
PFIZER INC.
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
Merck Sharp & Dohme LLC
$27
PROCEPT BioRobotics Corporation
$23
Antares Pharma, Inc.
$15
Ambu Inc.
$14
Teleflex LLC
$13
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$758
Endo Pharmaceuticals Inc.
$470
Dendreon Pharmaceuticals LLC
$356
AbbVie Inc.
$353
ABBVIE INC.
$192
UROGEN PHARMA, INC.
$185
BIOPROTECT MEDICAL, INC.
$163
Sumitomo Pharma America, Inc.
$147
PFIZER INC.
$137
NeoTract Inc.
$137
Myovant Sciences Inc.
$135
Medtronic, Inc.
$135
Retrophin, Inc.
$121
Myriad Genetic Laboratories, Inc.
$121
Laborie Medical Technologies Corp.
$119
Olympus America Inc.
$116
Janssen Biotech, Inc.
$70
Blue Earth Diagnostics Limited
$65
UroGen Pharma, Inc.
$64
AbbVie, Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$35
Sun Pharmaceutical Industries Inc.
$33
Merck Sharp & Dohme LLC
$27
PROCEPT BioRobotics Corporation
$23
TOLMAR Pharmaceuticals, Inc.
$22
Boston Scientific Corporation
$22
Clarus Therapeutics Inc.
$21
Smith+Nephew, Inc.
$20
Rochester Medical Corporation
$20
Antares Pharma, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Ambu Inc.
$14
Teleflex LLC
$13
Coloplast Corp
$13
RGH Enterprises, Inc.
$12
Aytu BioScience, Inc
$11
Top 3 companies account for 37.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AQUABEAM SYSTEM · Androgel · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · ELIGARD · Erleada · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · MYRBETRIQ · Natesto · Nubeqa · ORGOVYX · Olympus Laser Devices · POSLUMA · PROLARIS · PROVENGE · STRAVIX · UROLIFT · UroLift · VIRTUE · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Charlotte?
Compare opticians in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
190
Per 100K population
16.8
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Damani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Damani experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Damani performed 219 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Damani receive payments from pharmaceutical companies?
Yes. Dr. Damani received a total of $4,196 from 36 companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Damani's costs compare to other opticians in Charlotte?
Dr. Damani's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Damani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →